Endocontrol

Endocontrol specializes in laparoscopic instrument assist systems, including power-adjusted surgical assist arms and laparoscopic holder devices. Their primary focus is on the VIKY series, which is designed to stabilize and position instruments during minimally invasive surgeries. These devices are intended to reduce surgeon fatigue and enhance precision in procedures like general surgery, gynecology, and urology.

Endocontrol is headquartered in the United States. While the company’s exact market reach isn’t specified, its devices are tailored for laparoscopic applications, which are widely used in surgical settings globally. The focus is on improving surgical workflows by providing reliable instrument stabilization during minimally invasive procedures.

Endocontrol’s devices fall under Class II classification according to FDA regulations. This classification is typically assigned to devices that pose moderate risk and require special controls to ensure safety and effectiveness. The company’s products are authorised through the 510(k) premarket notification process, which demonstrates their compliance with FDA standards for similar existing devices.

Endocontrol’s devices are listed in the FDA’s 510(k) database and the FDA’s Unique Device Identifier (UDI) system. These registries ensure transparency and traceability of medical devices authorised for use in the U.S. The inclusion in these databases confirms compliance with FDA requirements for device identification and regulatory tracking.

The 510(k) pathway is used for devices that are substantially equivalent to legally marketed predecessors, meaning they share the same intended use and technological characteristics. Endocontrol’s devices likely meet this criterion, as they are designed to perform similar functions to existing laparoscopic assist systems. The UDI system ensures each device has a unique identifier for better tracking, safety monitoring, and regulatory compliance, which is mandatory for Class II devices in the U.S.